Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Viral Control”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT04362137
What this trial is testing

Study to Assess the Efficacy and Safety of Ruxolitinib in Patients With COVID-19 Associated Cytokine Storm

Who this might be right for
Cytokine Storm (Covid-19)
Novartis Pharmaceuticals 432
Testing effectiveness (Phase 2)Study completedNCT00000819
What this trial is testing

A Phase II Randomized, Double-Blind, Placebo-Controlled Trial to Determine the Efficacy of Prednisone Therapy in HIV-Associated Nephropathy (HIVAN)

Who this might be right for
HIV InfectionsAIDS-Associated Nephropathy
National Institute of Allergy and Infectious Diseases (NIAID) 54
Not applicableActive Not RecruitingNCT06603311
What this trial is testing

Finite Treatment of Hepatitis Delta With Bulevirtide: Identification of Biomarkers Associated With Sustained Control of HDV Infection

Who this might be right for
Compensated Liver Disease (Disorder)Hepatitis D, Chronic
Hannover Medical School 20
Not applicableStudy completedNCT00000844
What this trial is testing

A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled Trial of Three Preparations of Low-Dose Oral Alpha Interferon in HIV-Infected Patients With CD4+ Counts >= 50 and <= 350 Cells/mm3

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 560
Testing effectiveness (Phase 2)WithdrawnNCT04584697
What this trial is testing

Study to Evaluate the Safety, Pharmacokinetics and Efficacy of STI-2020 (COVI-AMG™) in Outpatients With COVID-19

Who this might be right for
Covid19
Sorrento Therapeutics, Inc.
Not applicableStudy completedNCT04828668
What this trial is testing

Study to Evaluate Benefits & Safety of Endourage Formula C™ Oral Drops in People With Post-Acute COVID-19 Syndrome.

Who this might be right for
Covid 19
Endourage, LLC 32
Large-scale testing (Phase 3)UnknownNCT04802382
What this trial is testing

Clinical Study Designed to Evaluate the Effect of CimetrA in Patients Diagnosed With COVID-19

Who this might be right for
Corona Virus InfectionCovid19SARS-CoV Infection
MGC Pharmaceuticals d.o.o 252
Early research (Phase 1)Study completedNCT01371162
What this trial is testing

RO5428029 in Healthy Volunteers and Patients With Chronic Hepatitis C

Who this might be right for
Hepatitis C, Chronic, Healthy Volunteer
Hoffmann-La Roche 42
Large-scale testing (Phase 3)Study completedNCT04328441
What this trial is testing

Reducing Health Care Workers Absenteeism in Covid-19 Pandemic Through BCG Vaccine

Who this might be right for
COVID-19
UMC Utrecht 1,511
Testing effectiveness (Phase 2)Study completedNCT02564523
What this trial is testing

Safety, Tolerability and Immunogenicity Study of 3 Prime-boost Regimens for Ebola Vaccines Ad26.ZEBOV/MVA-BN-Filo in Healthy Adults, Children and Human Immunodeficiency Virus Positive (HIV+) Adults

Who this might be right for
Hemorrhagic Fever, Ebola
Janssen Vaccines & Prevention B.V. 1,075
Testing effectiveness (Phase 2)WithdrawnNCT04401527
What this trial is testing

Treatment of Lung Injury From COVID-19 Infection With Intravenous Sodium Nitrite

Who this might be right for
COVID-19Acute Respiratory Distress SyndromeAcute Respiratory Failure
Hope Pharmaceuticals
Testing effectiveness (Phase 2)UnknownNCT00299897
What this trial is testing

SP01A: The Study of an Oral Entry Inhibitor in Treatment-Experienced HIV Patients

Who this might be right for
HIV InfectionsHuman Immunodeficiency Virus
Samaritan Pharmaceuticals, Inc 60
Testing effectiveness (Phase 2)Study completedNCT05156723
What this trial is testing

Study of the Immunogenicity, Safety and Tolerability of the Convacell Vaccine.

Who this might be right for
COVID-19Immunologic FactorsCoronavirus Infections+1 more
St. Petersburg Research Institute of Vaccines and Sera 155
Large-scale testing (Phase 3)Not Yet RecruitingNCT07833514
What this trial is testing

Misocholic Tablets for Non-Viral Elevated Liver Enzymes

Who this might be right for
Alcohol-Related Liver DiseaseDrug-Induced Liver InjuryNon-alcoholic Fatty Liver Disease
Hanoi Medical University 60
Large-scale testing (Phase 3)Study completedNCT01323244
What this trial is testing

TMC435 in Combination With Peginterferon Alfa-2A and Ribavirin for Hepatitis C Virus Genotype-1 Infected Patients Who Participated in a Control Group of a TMC435 Study

Who this might be right for
Hepatitis C
Janssen R&D Ireland 142
Testing effectiveness (Phase 2)Study completedNCT00035893
What this trial is testing

The Role of Ampligen in Strategic Therapeutic Intervention (STI) of HAART

Who this might be right for
HIV SeropositivityHIV Infection
AIM ImmunoTech Inc. 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT06537414
What this trial is testing

Sequential Therapy With Daplusiran/Tomligisiran (DAP/TOM) Followed by Bepirovirsen in Participants Living With Chronic Hepatitis B (CHB)

Who this might be right for
Chronic Hepatitis B Virus InfectionHepatitis B
GlaxoSmithKline 283
Testing effectiveness (Phase 2)Study completedNCT04335084
What this trial is testing

Hydroxychloroquine, Vitamin C, Vitamin D, and Zinc for the Prevention of COVID-19 Infection

Who this might be right for
COVID-19Coronavirus InfectionSars-CoV2+5 more
ProgenaBiome 254
Testing effectiveness (Phase 2)Study completedNCT04551911
What this trial is testing

Safety and Efficacy of Rayaldee for Treating Mild to Moderate COVID-19

Who this might be right for
COVID-19CoronavirusSARS-CoV2 Infection
OPKO Health, Inc. 171
Testing effectiveness (Phase 2)Study completedNCT00008463
What this trial is testing

A Comparison of the Effectiveness, Safety, and Tolerability of Two Different Hepatitis C Treatments in Patients Infected With Both HIV and Hepatitis C Virus (HCV)

Who this might be right for
HIV InfectionsHepatitis C
National Institute of Allergy and Infectious Diseases (NIAID) 132
Next Page